Triplet combination of durvalumab, tremelimumab, and paclitaxel in biliary tract carcinomas: Safety run-in results of the randomized IMMUNOBIL PRODIGE 57 phase II trial

Alice Boilève, Marc Hilmi, Paul Gougis, Romain Cohen, Benoı̂t Rousseau, Jean‐Frédéric Blanc, Méher Ben Abdelghani, H. Castanie, Laëtitia Dahan, David Tougeron, Jean‐Philippe Metges, Christophe Tournigand, Marie‐Line Garcia‐Larnicol, Déwi Vernerey, Anthony Turpin, Cindy Neuzillet